ArticleBiomolecules2026
Hyaluronan Signaling Ameliorates the Epithelial Injury Response and Barrier Disruption After Ozone Exposure.
Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Regenerative Functional Microspheres for Aesthetic Medicine: Mechanism, Materials, Fabrication, and Clinical Applications.Advanced healthcare materials · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Airway pollutants, like the reactive oxygen species ozone, cause significant lung injury, which can lead to the development or exacerbation of lung diseases like asthma and chronic obstructive pulmonary disease (COPD), and drives worldwide morbidity and mortality. Altered epithelial function is a hallmark and trigger of ozone-induced lung injury, but its precise mechanisms are incompletely known. The extracellular matrix, and specifically its major component, hyaluronan (HA), plays a crucial role in cellular injury responses. We hypothesized that HA signaling mediates epithelial responses to ozone-induced injury. We exposed human and murine differentiated primary epithelia to ozone in vitro and evaluated epithelial integrity and transcriptomic responses. We used genetically deficient cells for cognate HA receptors cluster of differentiation 44 (CD44) and receptor for HA-mediated motility (RHAMM), and innate immune receptors toll-like receptor 4 (TLR4) and TLR5 to study signaling pathways, and evaluated high molecular weight HA (HMWHA) as a potential treatment for ozone-induced epithelial injury. In vitro ozone exposure caused significant reduction in epithelial integrity and very similar inflammatory changes in human and murine cells. CD44 deficiency led to decreased inflammation, while RHAMM deficiency exacerbated cell injury. HMWHA protected against ozone-induced epithelial injury, mediated by TLR4 and TLR5 but not CD44 or RHAMM. Our results identify novel contributions of HA signaling to ozone-induced epithelial injury and suggest that HMWHA protects epithelia via innate immune activation of TLR4 and TLR5.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.